UCB's Anti-Convulsant Patent Is Valid, Delaware Judge Rules
A UCB Inc. patent for the anti-convulsant Vimpat is valid, a Delaware federal judge said in an opinion unsealed on Monday, blocking attempts by Actavis Inc., Mylan Pharmaceuticals Inc., Apotex Inc.....To view the full article, register now.
Already a subscriber? Click here to view full article